Jane Street
ICCC icon

Jane Street’s ImmuCell ICCC Stock Holding History

Jane Street’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Buy
+15,751
New +$139K ﹤0.01% 10304

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street's ICCC Position: Q2 2026 in Review

Jane Street opened a new position in ImmuCell (ICCC) in Q2 2026: 15,751 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #10304 among its holdings.

31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Jane Street held 15,751 shares of ImmuCell worth $158K as of Q2 2026.
  • ImmuCell was a new Jane Street position in Q2 2026.
  • ImmuCell made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10304 holding.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.